Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01350089
Other study ID # ED and alcohol intoxication
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 4, 2011
Last updated May 6, 2011
Start date January 2011
Est. completion date May 2012

Study information

Verified date May 2011
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority Austria: Ethikkommission
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the ingestion of caffeine, Energy Drinks has an effect on perceived alcohol intoxication.


Description:

In each of the four study periods, subjects will receive one of the four study treatments in a double blind, randomised, manner. The effects of study treatment on alcohol intoxication will be determined by measurement of breath alcohol concentration and subjective effects of intoxication. Safety and tolerability will be monitored by measurement of vital signs, in particular pulse, and review of adverse events.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 52
Est. completion date May 2012
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 26 Years
Eligibility Inclusion Criteria:

- Healthy male volunteers

- Able and willing to comply with the requirements of the study, confirmed by written informed consent

- Aged 20 to 26 years

- Within acceptable range for weight and body mass index (70-85 kg and 21 to 25 kg/m2)

- At least 12-14 years of formal education

- In good general health as determined by medical history and screening investigations (see below)

- Taking no regular medication

- No history of psychiatric disorders

- Moderate alcohol consumption (less than 190.4 g/week) according to the Daily Drink questionnaire (Collins et a., 1985)

- "sporadic" users of Energy Drinks (fewer than 10 cans of 250 ml in the last 6 months)

- Confirmation that the general practitioner/primary care physician knows no reason that would prevent their participation

- Similar in social and demographic data, similar quality of life

- similar patterns of use of alcoholic beverages and Energy Drinks as well as quality of life (Martinez et al., 2000)

- similar level of physical activity (physical activity questionnaire) (Baecke et al., 1982)

Exclusion Criteria:

- Any condition that the investigator and/or sponsor consider might increase the risk to the volunteer or decrease the chance of obtaining satisfactory data

- Consumed 2>x>4 caffeine-containing drinks/day within 3 months of screening

- Smoked >10 cigarettes/day or equivalent within 3 months of screening

- Consumed more than 190.4 g alcohol per week, or have a history of alcohol or drug abuse or

- Consumed less than one alcoholic drink per week

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Placebo (without alcohol, caffeine, energy drink)
(carbonated) water (volume equivalent to 46.5 g ethanol (inform of vodka (37.5%)) (carbonated) water (250 ml), artificial fruit juice (21 g/L prepared with (carbonated) water). The final volume of the mixture is 500 mL.
Comparator 1 (with alcohol; without caffeine and energy drink)
Mixture of 46.5 g ethanol (inform of vodka (37.5%)), (carbonated) water 250 mL, artificial fruit juice (21 g/L prepared with (carbonated) water). The final volume of the mixture 500 mL.
Comparator 2 (with alcohol and caffeine; without energy drink)
Mixture of 46.5 g ethanol (inform of vodka (37.5%)), caffeine (80 mg), (carbonated) water (250 ml), artificial fruit juice (21 g/L prepared with (carbonated) water) The final volume of the mixture is 500 mL.
Comparator 3 (with alcohol and energy drink)
Mixture of 46.5 g ethanol (inform of vodka (37.5%)), Red Bull® Energy Drink (250 mL, without flavour mixture to optimize blinding), artificial fruit juice (21 g/L prepared with (carbonated) water).The final volume of the mixture is 500 mL.

Locations

Country Name City State
Austria Medical University of Vienna, Deparment of pediatric and adolescent medicine Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in breath alcohol concentration from baseline up to 150 minutes No
Primary Changes of subjective effects of intoxication from baseline up to 120 minutes No
Secondary Safety and tolerability Safety and tolerability will be monitored by measurement of vital signs, in particular pulse, and review of adverse events. participants will be followed for the whole testing period of an expected average of 5 hours No
Secondary Changes in Supine and standing vital signs from baseline up to 150 minutes No

External Links